Vehicle with regenerative activity

 

(57) Abstract:

The invention relates to pharmacology, in particular - to biologically active substances possessing regenerative activity. To increase the effectiveness of treatment and expand the scope of the mixture in the treatment of previously not vylechivaya fully diseases, such as integrated (combined) gastrointestinal diseases, in a biologically active mixture of amino acids was increased to eighteen and also introduced advanced micro - and macronutrients.

The invention relates to pharmacology, in particular biologically active mixtures of substances and chemical elements used for the recovery of vital protective functions of the human body, and can be used in the treatment of gastrointestinal diseases.

Known means, possessing regenerative activity and contains proteins, valine. isoleucine, leucine, methionine, tryptophan, phenylalanine. However, the effectiveness of this tool is limited by the inability of treatment except for diffuse liver disease of various diseases of the gastrointestinal tract that prevents to obtain a technical result.

The invention is based on increasing efficiency and reducing treatment time previously not fully cure disease complex (combined) gastrointestinal diseases with other diseases (antecolic, pancreatitis, policestate, AC), which is the technical result of the present invention.

The essential features characterizing the invention and sufficient in all cases to which the requested scope of legal protection are alanine, arginine, aspartic acid, valine, histidine, glycine, glutamic acid, isoleucine. leucine, lysine. methionine, Proline, serine, tyrosine, threonine. phenylalanine, cystine, as well as rganic, copper, molybdenum, sodium, Nickel, sulfur, titanium and phosphorus with the following ratios, wt. alanine 0,35-1,40; aminobutyric acid 0,0001-0,0010; arginine 0,15-0,27; aspartic acid and 0.2-0.5; valine 0,03-0,04; histidine 0,15-0,27; glycine is 2.5-4.3; glutamic acid 0,25-4,70; isoleucine 0,03-0,10; leucine 0,05-0,14; lysine 0,008-0,110; methionine 0,010-0,018; Proline 0,12-1,50; serine 0.08 to 0.14; tyrosine 0,03-0,05; threonine 0,07-0,15; phenylalanine 0,040-0,095; cystine 0,10-0,12; aluminum 0,000394-0,004300; iron 0,0012-0,0240; potassium 1,0000-6,6224; calcium 0,1632-1,7439; silicon 0,001998-0,016240; Li 0,0000328-0,0002375; magnesium 0,1299-2,2389; manganese 0,005312-0,005830; copper 0,000181-0,001500; molybdenum 0,0000021-0,0001750; sodium 0,2487-7,2922; Nickel 0,0000169-0,0004621; sulfur 0,010-0,100; titanium 0,0000238-0,0002340; phosphorus 0,00204-0,01928; the rest is filler.

Described in the formula ingredients are mixed together, for example, by means of the centrifugal chamber for 10-15 minutes, after which the mixture soak for 10-15 h in water at 40-50oWith, stirring occasionally.

Then, the resulting liquid mass defend 2-3 h and the liquid part is drained. The remaining mass is evaporated at 95-100oC for 1-1 .5 hours and crushed to powder mass.

Depending on the percentages of ingredients while mixing at the beginning of the process the obtained powder mass is diluted voltage is

Examples of the use of funds.

Example 1. Patient C. was treated in the outpatient setting after unsuccessful treatment in various medical institutions in Sri concerning gastric ulcer and duodenal ulcer in combination with disease holetsistitom. Peptic ulcer disease had continuously relapsing course, probcause ulcers occurred during 8 months.

On the eighth day of treatment disappeared pain points in piloroduodenalnoy region, in areas Shaffer, Gubergrits. Ulcers healed in the third week of treatment, and after a full cycle of treatment in this tool ulcerative effects were not detected for 1.5 years, and revealed no signs of policestate.

The treatment was carried out for ten days and then five days break in a period of ten days taking on an empty stomach with 0.5 g of product containing wt. alanine 0,35; aminobutyric acid 0,0001; arginine 0,15; aspartic acid 0,2; valine 0,03; histidine 0,15; glycine 2,5; glutamic acid 0,25; isoleucine 0,03; leucine 0.05; lysine 0,008; methionine 0,01; Proline 0,12; serine 0,08; tyrosine 0,03; threonine 0,07; phenylalanine 0,04; cystine 0.1; aluminum 0,000394; iron 0,0012; potassium 1,0; calcium 0,1632; silicon 0,001998; Li 0,0000328; magnesium 0,1299; manganese ASS="ptx2">

Example 2. The patient So treated by the tool in the outpatient setting after unsuccessful treatment in various medical institutions and research institutes regarding stomach ulcers, dvenadcatiperstnoy ulcer in combination with pancreatitis. Peptic ulcer disease had continuously relapsing course, probcause ulcers occurred during the 12 months.

On the fifth day after administration of this tool on an empty stomach daily withdrew pain syndrome, normalized stool, decreased bloating, showed interest in life.

On the ninth day of treatment disappeared pain points in piloroduodenalnoy region, in areas Shaffer, Gubergrits. Ulcers healed in the third week of treatment, and after a full cycle of treatment in this tool ulcerative effects were not detected for 1.5 years, as well as manifestations of pancreatitis.

The treatment was carried out for ten days and five days break in a period of ten days taking on an empty stomach with 0.5 g of product containing, by weight. alanine 1,4; aminobutyric acid 0,001; arginine 0,27; aspartic acid 0,5; valine 0,04; histidine 027; glycine 4,3; glutamic acid 4,7; isoleucine 0.1; leucine 0,14; lysine 0,11; methionine 0,018; Proline 1,5; serine 0,14; tyrosine 0.05; threonine 0,15; FeNi who Ganz 0,00583; copper 0,0015; molybdenum 0,000175; sodium 7,2922; Nickel 0,0004621; sulfur 0.1; titanium 0,000234; phosphorus 0,01928; the rest of the starch.

Vehicle with regenerative activity, including alanine, arginine, aspartic acid, valine, histidine, glycine, glutamic acid, isoleucine, leucine, lysine, methionine, Proline, serine, tyrosine, threonine, phenylalanine, cystine, characterized in that it further comprises aminobutyric acid, aluminum, iron, potassium, calcium, silicon, lithium, magnesium, manganese, copper, molybdenum, sodium, Nickel, sulfur, titanium, phosphorus and filler at a ratio of components, wt.

Alanine 0,35 1,40

Aminobutyric acid 0,0001 0,0010

Arginine 0,15 0,27

Aspartic acid 0,2 0,5

Valine 0,03 0,04

Histidine 0,15 0,27

Glycine 2,5 4,3

Glutamic acid 0,25 4,70

Isoleucine 0,03 0,10

Leucine 0,05 0,14

Lysine 0,008 0,110

Methionine 0,010 0,018

Proline 0,12 1,50

Serine 0,08 0,14

Tyrosine 0,03 0,05

Threonine 0,07 0,15

Phenylalanine 0,040 0,095

Cystine 0,10 0,12

Aluminum 0,000394 0,0043

Iron 0,0012 0,024

Potassium 1,0000 6,6224

Calcium 0,1632 1,7439

Silicon 0,001998 0,01624

Li 0,0000328 0,0002375

Magnesium 0,1299 2,2389

Manganese 0,005312 0,00583

Copper 0,000181 0,0015

Molybdenum 0,00001928

Filler Ostalnoe

 

Same patents:
Skin cream // 2079300
The invention relates to the field of cosmetology and can be used for skin care children

The invention relates to the field of cosmetology, namely, a cosmetic treatment in the form of biocrime, prevent skin aging
The invention relates to cosmetics and pharmaceutical industry, and specifically to cosmetic and medicinal creams
The invention relates to space assets to care for skin

The invention relates to cosmetic and therapeutic medicine
The invention relates to biologically active substances from the needles used in cosmetics and soap industry

Cosmetic milk // 2073506
The invention relates to cosmetology, and in particular to means for removing make-up and make-up
The invention relates to the cosmetic industry and allows you to retain the bioactivity of the additives of vegetable or animal origin in the process of getting cream

The invention relates to the cosmetic industry, in particular to the production of liquid products - lotions, balms, etc. and can be used for skin care of the face, hands, body, and scalp and hair roots

The invention relates to the field of medicine and for the production of cream for power, protection and prevention of skin aging
The invention relates to medicine, in particular to biologically active mixtures of substances used to restore the protective functions of the human body

The invention relates to a process for the production of lysozyme from egg white
The invention relates to medicine and can be used in therapeutic and prophylactic purposes for increase nonspecific resistance of a person to adverse environmental factors, and acute respiratory viral infections, reduce the severity and duration of treatment of diseases
The invention relates to medicine and can be used in therapeutic and prophylactic purposes for increase nonspecific resistance of a person to adverse environmental factors, and acute respiratory viral infections, reduce the severity and duration of treatment of diseases
The invention relates to medicine, specifically to methods of treatment of bone cysts in children

The invention relates to a new antitumor chromophore derived from cedarcide antibiotic

The invention relates to medicine and related compounds with protivotarannymi action

FIELD: biotechnology, biochemistry.

SUBSTANCE: invention relates to producing the biologically active complex eliciting antioxidant and immunomodulating activity and used in medicine, cosmetics, veterinary science and food industry. The biologically active complex preparing by enzymatic hydrolysis of muscle tissue represents complex of biologically active compounds involving carnosine and anserine in the amount 85-97 wt.-% of the native content of these components in poultry muscle tissue, 1-7 weight parts of amino acids, 0.5-12 weight parts of oligopeptides of molecular mass 10 kDa, not above, and 0.1-15 weight parts of cyclic and polycyclic phenolic compounds as measured for 1 weight part of carnosine and anserine in the complex. This complex is prepared by enzymatic hydrolysis of milled and homogenized water muscle tissue in preferable dilution homogenate with water in the range 0.2-0.6 and with using proteolytic enzymes in the amount 2-5 wt.-% of the protein content and working at pH 4.5-8.5 and at enhanced temperature being preferably at 45-65°C. Product is isolated as extract or powder prepared in drying the extract. Invention provides enhancing effectiveness of the claimed complex.

EFFECT: improved method for preparing, valuable properties of complex.

7 cl, 6 tbl, 6 ex

FIELD: medicine.

SUBSTANCE: the present innovation deals with treating vestibular and auditory disorders, trigeminal nerve's neuralgia and peripheral paresis of facial nerve of herpetic etiology. The method deals with introduction of an antiherpetic preparation followed by immunomodelling therapy with the use of polyoxidonium. Moreover, after treating with antiherpetic preparation before introducing polyoxidonium it is necessary to conduct additional successive therapy: with preparations of trophic action as milgamma or neuromultivit at simultaneous introduction of antioxidant, then comes intratissue injection of cerebrolysine being behind the top of mastoid process.

EFFECT: the innovation enables to decrease the quantity of relapses due to stopping the development of herpes simplex virus, restore conductivity along nervous fiber and improve endoneural circulation.

3 cl, 3 ex

Up!